CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $103,000 | – | 11,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 2,757,260 | $8,299,000 | 4.68% |
Tamarack Advisers, LP | 1,825,000 | $5,493,000 | 3.43% |
CLOUGH CAPITAL PARTNERS L P | 2,958,415 | $8,905,000 | 0.56% |
AlphaOne Investment Services, LLC | 550,712 | $1,653,000 | 0.42% |
Rock Springs Capital Management LP | 1,200,000 | $3,612,000 | 0.21% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 4,894,948 | $14,734,000 | 0.13% |
KNOTT DAVID M | 76,300 | $230,000 | 0.11% |
SABBY MANAGEMENT, LLC | 273,010 | $819,000 | 0.04% |
PUTNAM INVESTMENTS LLC | 3,438,484 | $10,315,000 | 0.02% |
ARDSLEY ADVISORY PARTNERS LP | 40,000 | $120,000 | 0.02% |